Clorox has been on a significant journey recently. With a recovery story gaining momentum, Nordea Investment Management divests from Clorox, while
Sumitomo Mitsui DS Asset Management and
Virginia Retirement Systems increase their positions. The company backs a global effort motivated by MLK, offers daily spray that neutralizes indoor allergens and faces several price target cuts from leading financial firms such as Wells Fargo, UBS and JP Morgan primarily due to uncertainty in 2026's staples models. New
options are available for Clorox, coupled with Q1 fiscal year 2026 results having been announced. Bank of America slashes the company's target, citing future uncertainty of consumer staples. Meanwhile,
Clorox declares a quarterly dividend of $1.24 per share. Investment firms are making recommendations based on the company's recent movements and dividends, with varied opinions shared about Clorox's perceived undervaluation and long-term share price slump. Their product,
PURE Allergen Neutralizer seeks to redefine indoor wellness market and provide a new way to stop allergens. Clorox also broadens its global mobilization partnership with
Realize The Dream.
Clorox Company CLX News Analytics from Tue, 25 Mar 2025 07:00:00 GMT to Sat, 17 Jan 2026 22:39:07 GMT -
Rating -2
- Innovation 3
- Information 6
- Rumor -8
